HOME >> BIOLOGY >> NEWS
Columbia scientists determine 3-dimensional structure of cell's 'fuel gauge'

NEW YORK -- Researchers at Columbia University Medical Center have uncovered the complex structure of a protein that serves as a central energy gauge for cells, providing crucial details about the molecule necessary for developing useful new therapies for diabetes and possibly obesity. A paper published online today in the journal Science details this structure, helping to explain one of the cell's most basic and critical processes.

"Understanding this important protein's molecular structure and mechanism provides a major step forward for the rational design of new drugs to target diabetes and obesity," said Lawrence Shapiro, Ph.D., associate professor of Biochemistry and Jules and Doris Stein Professor of Research to Prevent Blindness at Columbia University Medical Center, and senior author of the paper.

The protein, known as AMP-activated protein kinase or AMPK, controls metabolic decisions of cells. For example, it controls the decision regarding whether fat is stored or burned, based on the amount of energy in the cell. When the energy level of a cell is high, meaning that the cell contains high amounts of an energy-carrying molecule known as ATP, AMPK directs cells toward "anabolic" activities like storing the extra energy as fat. When ATP is low, AMPK turns off anabolic activities, and activates "catabolic" functions, like burning fat to make energy.

AMPK provides an especially promising drug target for people with type 2 diabetes. These patients are insulin-resistant, meaning that their cells are not responsive to insulin which normally helps glucose get out of the bloodstream, where it does damage, and into cells. When AMPK detects low levels of ATP in the cell, it works through a different mechanism to increase how much glucose the cell takes in and uses to create ATP. Research in rodent models has shown that AMPK activators can lessen the pathologies associated with diabetes, including problems that diabetics have r
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
8-Feb-2007


Page: 1 2

Related biology news :

1. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
2. Columbia University licenses next-generation DNA sequencing technology
3. New bird discovered on unexplored Columbian mountain
4. Columbia University Medical Center receives major new NIH Clinical Science investment funds
5. Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription
6. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
7. Contaminants linked to sturgeon decline in Columbia river
8. Columbia University Medical Center researchers discover potential mechanism for tumor growth
9. UF, Columbia scientists closer to new cancer detection method
10. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist
11. Columbia wins major grant to examine genetic link to Alzheimers Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 16, 2019 , ... January has been a record-breaking month so far ... has the company already hosted several of its signature cooking classes and team-building events, ... Pharmaceuticals, later this month. , Since 2008, Lajollacooks4u’s team-building events have been a ...
(Date:1/14/2019)... ... January 14, 2019 , ... ... detect precancer and cancer cells in blood, will present new findings at the ... the fight against colorectal cancer. The results from this study show CellMax Life’s ...
(Date:1/10/2019)... ... , ... When Dr. James L. Sherley, M.D., Ph.D., founder and director of ... to the new book Perinatal Stem Cells: Research and Therapy, he knew immediately what ... secret of stem cell medicine. For more than a half-century, stem cell medicine ...
Breaking Biology News(10 mins):
(Date:2/12/2019)... (PRWEB) , ... February 12, 2019 , ... ... in dermatology, has finalized a deal to extend their use of Medrio, the ... trials, through 2023. The CRO has been a regular Medrio customer for over ...
(Date:2/2/2019)... ... January 31, 2019 , ... Signature Matrix and ... perinatal tissue by applied stem cell research expert and Amazon best-selling author, Neil ... a flowable umbilical cord tissue allograft that originates from the same tissue used ...
(Date:1/30/2019)... ... 29, 2019 , ... Mr. Schieving has served as the ... Director of Sales and Marketing, Mr. Schieving was instrumental in positioning Lifecycle as ... supports. During this time, Mr. Schieving was responsible for establishing internal and external ...
(Date:1/30/2019)... N.J. (PRWEB) , ... January 30, 2019 , ... ... together experts from pharma, academia and governmental agencies to discuss best practices for ... DC from February 4-6. , At this year’s conference, Visikol will be ...
Breaking Biology Technology:
Cached News: